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CASE REPORT
Loss of alpha-smooth muscle actin 
expression associated with chronic intestinal 
pseudo-obstruction in a young Miniature Bull 
Terrier
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Abstract 
Background: Chronic intestinal pseudo-obstruction (CIPO) is a rare clinical syndrome in veterinary medicine charac-
terized by severe intestinal dysmotility without evidence of mechanical occlusion of the intestinal lumen. The exact 
pathogenesis of CIPO is unknown.
Case presentation: A 1-year-old male Miniature Bull Terrier dog was presented with a history of chronic weight loss, 
regurgitation, lethargy, vomiting and diarrhea. The dog was submitted for exploratory laparotomy. A full thickness 
intestinal biopsy was taken and a CIPO was suspected. The clinical condition deteriorated and the dog was eutha-
nized. At gross examination the small intestine was severely dilated. Histologically severe fibrosis of the submucosa 
and severe atrophy of the tunica muscularis were present in small intestine and colon. Immunohistochemical exami-
nation with a panel of antibodies for gastro-intestinal neuromuscular disease-associated antigens revealed a severely 
reduced expression of alpha-smooth muscle actin in the tunica muscularis.
Conclusions: This case report describes the gross, histological and immunohistochemical findings of CIPO affecting 
a 1-year-old Miniature Bull Terrier; on the basis of these findings a myopathic form of CIPO is hypothesized in this case.
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Background
Chronic intestinal pseudo-obstruction (CIPO) is a rare 
clinical syndrome in veterinary medicine character-
ized by severe intestinal dysmotility without evidence 
of mechanical occlusion of the intestinal lumen. In the 
veterinary literature, few cases of CIPO affecting dogs, 
horses and cats have been reported [1–10]. In human 
medicine, CIPO can be caused by different gastrointes-
tinal neuromuscular diseases (GINMDs) including pri-
mary visceral neuropathies, interstitial cell diseases and 
myopathies, where different neurointerstitial-muscular 
components are involved [11, 12].
In dogs, most cases have been related to an idiopathic 
fibrosing enteropathy or fibrosing gastrointestinal leio-
myositis, or less frequently to dysautonomia [4, 5, 7–10, 
13]. Due to the rarity of this condition and appropri-
ate studies, the pathogenic mechanisms are still poorly 
understood. This case report describes the gross, histo-
logical and immunohistochemical findings in a young 
Mini Bull Terrier affected by CIPO.
Case presentation
A 1-year-old male Miniature Bull Terrier dog was pre-
sented with a 2-month history of chronic weight loss, 
regurgitation, lethargy, vomiting and diarrhoea. The dog 
received prokinetic treatment, antiemetics, antimicro-
bial agents, and intravenous fluid therapy, without sig-
nificant clinical improvement. Abdominal radiographs 
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revealed marked small intestinal dilation. On explora-
tory laparotomy, the small intestine was not obstructed 
but appeared markedly distended and a full-thickness 
biopsy of the jejunum was taken. Histological examina-
tion revealed severe atrophy of the tunica muscularis and 
fibrosis of the tunica submucosa and a diagnosis of CIPO 
or neuromuscular disorder was suspected. Following the 
histopathological examination, the dog was unsuccess-
fully treated with glucocorticoids. Due to the persistent 
clinical signs of dysmotility, the dog’s clinical condition 
severely deteriorated thus euthanasia was elected.
At necropsy the dog appeared dehydrated, in poor 
nutritional condition and with minimal body fat 
amounts. The small intestine was severely dilated and 
filled by a variable amount of grey-greenish fluid (Fig. 1). 
The esophagus, stomach and the large intestine were 
also dilated but to a lesser extent. The small intestinal 
wall was diffusely thinned and atonic. Tissues samples, 
including specimens of the thoracic and abdominal 
organs, the skin and skeletal muscle were taken for histo-
pathology as were parts of the oesophagus, the stomach, 
the duodenum, the jejunum, the ileum, the cecum, the 
colon and the rectum. The samples were fixed in 4% neu-
tral-buffered formaldehyde for 48  h. After fixation, the 
specimens were processed by an automatic histoproces-
sor and embedded in paraffin. Serial sections (3 µm) were 
stained with hematoxylin and eosin (HE), periodic acid-
Schiff (PAS) technique and Masson’s trichrome method. 
For immunohistochemistry, sections of stomach, duo-
denum, jejunum, ileum, cecum, colon and rectum tract 
were mounted on  Superfrost®Plus slides and an avidin–
biotin–peroxidase-complex (ABC) technique with diam-
inobenzidine as the chromogen was performed. A panel 
of antibodies to the following antigens was used: alpha-
smooth muscle actin (α-SMA) (smooth muscle cells, 
myofibroblast; monoclonal, clone 1A4, Sigma-Aldrich, 
St. Louis, USA), CD3 (T-lymphocytes; monoclonal, clone 
CD3-12 Bio-Rad, UK), CD79a (B-lymphocytes; monoclo-
nal, clone HM57, Bio-Rad, UK), CD117 (interstitial cells 
of Cajal, polyclonal, Santa Cruz Biotechnology, USA), 
glial fibrillary acid protein (GFAP) (enteric glial cells; 
polyclonal, Dako, Glostrup, Denmark), neurofilaments 
(neurons; monoclonal, clone2F11, Dako), neuron spe-
cific enolase (NSE) (neuronal and neuroendocrine cells; 
polyclonal, Calbiochem, USA), S-100 (enteric glial cells; 
polyclonal, Dako), and synaptophysin (neuronal and 
neuroendocrine cells; monoclonal, Dako). Appropriate 
negative and positive controls including gastrointestinal 
tissue sections of an healthy dog were used for the immu-
nohistochemical analyses. The specificity of the different 
antibodies was evaluated considering the information 
available in the datasheet for each antibody. Moreover, 
the specificity and cross-reactivity of the antibodies were 
evaluated based on published studies [14–19].
Histological findings for duodenum, jejunum, ileum, 
cecum, colon and rectum consisted of severe diffuse atro-
phy of the tunica muscularis and severe locally-extensive 
to diffuse fibrosis of tunica submucosa as demonstrated 
by Masson’s trichrome stain (Fig. 2a–d). Similar but less 
severe fibrosis was present within the submucosa of the 
stomach. The lamina muscularis mucosae appeared 
moderately hypertrophic (Fig.  2a–d). Additionally, the 
intestinal mucosa of duodenum and ileum appeared 
multifocally eroded and within the tunica submu-
cosa and the tunica muscularis, multifocal moderate to 
severe lymphangiectasia was observed. The myenteric 
and submucosal nerve plexuses of all segments of the 
gastrointestinal tract had intact neurons confirmed by 
immunohistochemistry for NSE, neurofilaments and 
synaptophysin (Fig.  3a–c). Few lymphocytes as well as 
cells staining positive for GFAP were observed within 
interstitium or within myenteric plexuses respectively. 
Also interstitial cells of Cajal were preserved and were 
strongly stained for CD117 (Fig.  3d). However, α-SMA 
immunoreactivity was diffusely and markedly reduced 
in the muscular layers of all gastrointestinal segments 
examined with foci of complete loss compared to the 
control (Fig. 4a–d).
Discussion and conclusions
In veterinary medicine, most of the reported cases of 
canine CIPO were histologically characterized by fibrosis 
and muscular atrophy of the gastro-intestinal tract along 
with variable inflammation centred on the tunica muscu-
laris (leiomyositis) [4, 5, 7, 8]. In the present case, there 
was segmental fibrosis of the submucosa and severe atro-
phy of tunica muscularis but the inflammatory compo-
nent was minimal, similarly to other canine CIPO cases 
[1, 10, 20]. This finding was also observed in the initial 
intestinal biopsy when the corticosteroid therapy had not Fig. 1 Small intestine with diffuse severe dilation
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yet been initiated. Hypertrophy of the lamina muscula-
ris mucosae was present as also reported by others [1, 10, 
20].
In human medicine, immunohistochemistry is used in 
order to discriminate between different forms of CIPO: 
myopathic, neuropathic and those caused by abnormali-
ties of the interstitial cells of Cajal, by means of a panel of 
antibodies able to identify which neurointerstitial-mus-
cular component is involved [11, 12, 21]. In numerous 
human GINMD cases, loss of α-SMA immunoreactivity 
was the only finding and has been associated with CIPO 
[21–23]. In human medicine, the consensus statement 
created by an international working group defined diag-
nostic algorithms and techniques for evaluating GINMD 
Fig. 2 a, b Jejunum. Severe fibrosis of the tunica submucosa (asterisk), hypertrophy of the lamina muscularis mucosae (arrowhead) and severe 
atrophy of the tunica muscularis (arrow). c, d Colon. Severe fibrosis of tunica submucosa (asterisk), hypertrophy of the lamina muscularis mucosae 
(arrowhead) and severe atrophy of tunica muscularis (arrow). (a and c: HE; b and d: Masson’s trichrome, obj. ×4)
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and consider loss of α-SMA expression as a marker for 
a myopathic form of CIPO [11, 12, 21]. Whether an 
α-SMA abnormality is the cause of altered motility is 
unknown. Recently, a case of CIPO associated with defi-
cient expression of α-SMA in the muscular layer and loss 
of myofibrils has been described in a Bengal cat and a 
leiomyopathy was hypothesized [24]. In our case, the loss 
α-SMA immunoreactivity was diffuse affecting both the 
inner circular layer and longitudinal layer of the tunica 
muscularis and the lamina muscularis mucosae in con-
trast to the human cases and the feline case where only 
the circular layer appeared involved.
Neuropathy was not considered in our case due to 
the lack of enteric nervous plexus inflammation and the 
absence of neuronal degeneration. Additionally, the dog 
did not exhibit clinical signs consistent with dysautono-
mia. The clinical, histopathological and immunohisto-
chemical findings of this rare case diagnosed with CIPO 
is consistent with enteric myopathy and intestinal fibrosis 
and could be referred to a myopathic form of GINMDs. 
In another CIPO case affecting a Pug, there was also a 
marked segmental loss of α-SMA expression in the intes-
tinal muscular layer [20]. These findings suggest a possi-
ble crucial role of α-SMA in the pathogenesis of this still 
poorly understood condition.
Fig. 3 Immunohistochemical findings in the jejunum. a Submucosal nerve plexuses with neurons positive for NSE (asterisk). b Submucosal nerve 
plexuses immunopositive for neurofilaments (asterisk). c Submucosal nerve plexuses immunopositive for synaptophysin (asterisk). d Submucosa. 
Interstitial cells of Cajal immunostained for CD117 (arrow). IHC counterstained with hematoxylin (obj. ×4)
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In conclusion, the present case report describes the 
first CIPO case described in a Miniature Bull Terrier 
and highlights the importance of immunohistochemical 
examination in order to characterize the type of GIN-
MDS and add new information about the underlying 
pathogenic mechanisms. Further studies at the genetic 
level are necessary to explain if loss of α-SMA expression 
is associated with a specific genetic disorder.
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Fig. 4 Immunohistochemical findings for α-SMA. a Jejunum. Diffuse low expression within the inner circular layer and the longitudinal layer of 
tunica muscularis. (arrow) Small vessels appear positive for α-SMA (asterisk). b Colon. Diffuse reduced expression within the tunica muscularis 
(arrow). c Stomach. Diffuse loss of expression within the tunica muscularis (arrow). Wall of a medium vessel positive for α-SMA (asterisk). d Normal 
canine duodenum. Diffuse intense α-SMA expression of the tunica muscularis. a–d IHC counterstained with haematoxylin (obj. ×10)
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